During the past decade, Lancaster Heart Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lancaster Heart Foundation" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lancaster Heart Foundation" are "Heart Failure" (2 trials), "Arrhythmia" (1 trials), "Heart Failure, Congestive" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Lancaster Heart Foundation" in a lesser frequency.

Most popular intervention types in "Lancaster Heart Foundation" are "Device" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-minutes walk performance" (1 trials), "Azimilide Dihydrochloride" (1 trials), "Blood sampling for laboratory tests" (1 trials), "CRT-D and LV lead (Quartet™ lead and Promote Q® device system)" (1 trials) and "Dyspnea severity assessment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lancaster Heart Foundation" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Lancaster Heart Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lancaster Heart Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lancaster Heart Foundation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".